PIK3C3 and breast carcinoma: Yasmin Yu then reported the activities of a novel, selective phosphatidylinositol-3-kinase Vps34 inhibitor developed by Sprint Bioscience, which inhibits autophagy and decreases the growth of human breast carcinomas.